Synapse - David Solit

Results (783)

Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy

Editorial

Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
European Urology (2019)

Fulltext@MSK | Save

Lobular carcinomas in situ display intralesion genetic heterogeneity and clonal evolution in the progression to invasive lobular carcinoma

Journal Article

Lee, J. Y.; Schizas, M.; Geyer, F. C.; Selenica, P.; Piscuoglio, S.; Sakr, R. A.; Ng, C. K. Y.; Carniello, J. V. S.; Towers, R.; Giri, D. D.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)

Meeting Abstract

Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas

Meeting Abstract

Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Clonal concordance and genomic heterogeneity in single CTC copy number alterations vs. paired IMPACT metastatic tissue sequencing from mCRPC patient samples

Meeting Abstract

Scher, H. I.; Dago, A. E.; Lee, J.; Sutton, R.; Graf, R. P.; Schreiber, N. A.; Hullings, M.; Wang, Y.; Landers, M. A.; Solit, D. B.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Frequency of actionable cancer predisposing germline mutations in patients with lung cancers

Meeting Abstract

Mukherjee, S.; Zauderer, M. G.; Ravichandran, V.; Kemel, Y.; Mandelker, D.; Pradhan, N.; Zehir, A.; Lipkin, S. M.; Srinivasan, P.; Bandlamudi, C.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers

Meeting Abstract

Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)

Meeting Abstract

Janjigian, Y. Y.; Jonsson, P.; Kemel, Y.; Joseph, V.; Tuvy, Y.; Shameer, Z.; Ravichandran, V.; Zhang, L. Y.; Mandelker, D.; Ku, G. Y.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)

Meeting Abstract

Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Genomic landscape, clinical characteristics and outcomes of early onset (EO) compared with average onset (AO) colorectal cancer (CRC)

Meeting Abstract

Dos Santos Fernandes, G.; Chatila, W. K.; Yaeger, R.; Mendelsohn, R. B.; Stadler, Z. K.; Segal, N. H.; Varghese, A. M.; Lagunes, D. R.; Diaz, L. A.; Shia, J.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save